Search

everythinglearnresearchcommunity

for

Search:↓

The review found that PRP is the most effective treatment for hair loss with few side effects.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

A 3-year-old boy was diagnosed with a rare, non-scarring hair loss condition called temporal triangular alopecia.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

Acne keloidalis nuchae is a chronic skin condition more common in African men, causing itchy or painful bumps and can lead to permanent hair loss if not treated early.

Women in Australia report different signs of facial aging compared to women in the US, UK, and Canada; men with Lichen planopilaris often have hormonal abnormalities and thyroid disease.

Most men with lichen planopilaris had it confirmed by biopsy and often had thyroid issues, sexual dysfunction, or prostate cancer, hinting at a link with hormonal problems.

Cryotherapy may be an effective and simple treatment for mild hair loss with few side effects.

Some African American women experience central scalp hair loss, often linked to a history of fungal scalp infection.

Keratosis Pilaris Atrophicans causes skin scarring and might be treated with a new synthetic retinoid.

Microneedling with PRP and minoxidil (5%) improves hair growth more than minoxidil (5%) alone.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Finasteride effectively treats hidradenitis suppurativa for most patients.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Platelet-rich plasma treatment could potentially be an effective way to treat chronic alopecia areata with minimal side effects.

Acne keloidalis nuchae is a tough-to-treat condition that greatly affects quality of life, especially in men of African descent.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Using both vertical and transverse sections gives a better diagnosis of alopecia than using one method alone.

The conclusion is that high-potency steroids or tacrolimus are effective treatments for erosive pustular dermatosis of the scalp.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Aconiti Ciliare Tuber extract may help hair grow by activating a specific cell signaling pathway.

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.